The entities hope to confirm the JC virus’ involvement in colorectal cancer and possibly identify other microbial or genetic factors. Investigators at BRI have previously conducted research that strongly suggests that the JC virus is responsible for initiating some or perhaps most colorectal cancers.
Read the news release about BRI and Eureka Genomics.
Read other coverage about colorectal cancer:
– CRC Drug Huge Disappointment to GI Physicians
– Adenoma Detection Rate Associated With Risk of CRC
– GI Societies Urge Congress to Fund CDC’s Colorectal Cancer Control Program
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.